Insider Buying: International Biotechnology (LON:IBT) Insider Purchases 6,996 Shares of Stock

International Biotechnology (LON:IBT - Get Free Report) insider Alexa Henderson purchased 6,996 shares of the stock in a transaction dated Wednesday, February 19th. The shares were purchased at an average cost of GBX 711 ($8.98) per share, for a total transaction of £49,741.56 ($62,844.67).

International Biotechnology Stock Performance

Shares of IBT stock traded up GBX 4 ($0.05) on Friday, hitting GBX 720 ($9.10). 86,622 shares of the stock traded hands, compared to its average volume of 72,494. The firm's 50-day moving average price is GBX 702.28 and its two-hundred day moving average price is GBX 691.58. The stock has a market capitalization of £258.63 million, a PE ratio of 6.87 and a beta of 0.21. International Biotechnology has a twelve month low of GBX 596 ($7.53) and a twelve month high of GBX 736 ($9.30).

International Biotechnology Increases Dividend

The business also recently announced a dividend, which was paid on Friday, January 24th. Shareholders of record on Thursday, December 19th were given a GBX 15.56 ($0.20) dividend. The ex-dividend date of this dividend was Thursday, December 19th. This represents a yield of 2.21%. This is a boost from International Biotechnology's previous dividend of $14.50. International Biotechnology's dividend payout ratio is presently 27.67%.

International Biotechnology Company Profile

The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.